- VERONICA WATSON
Otolaryngology Morbidity and Mortality Conference is designed for practitioners in the field of Otolaryngology or related medical fields who may benefit from enhancement in medical knowledge, patient care, practice-based learning and improvement, interpersonal communication skills, professionalism, and systems-based practice in otolaryngology. Morbidity and mortality reports from each clinical site are presented once per month. Complications or systems-based issues are presented by the resident. This process involves reviewing the hospital course for that patient along with a review of published literature pertaining to the complication or systems-based issue.
The target audience for this course includes MDs, DOs, Residents/Fellows, and Students.
|Thomas Pasic, MD, FACS, Chair||Veronica Watson, MSOD, Coordinator|
|Tiffany Glazer, MD||Tony Kille, MD|
|Luca Leonhard, MD||Dana Gilbertson|
|Chad Ennis, MD|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee
Disclosures for Planning Committee - March 1, 2022 to June 30, 2022
As a result of participation in this educational series participants will:
- Improve patient care in otolaryngology through productive conversation and collaboration among members of the healthcare team.
- Modify behavior and judgment, based on previous experiences, to prevent repetition of errors leading to complications and to reduce adverse outcomes
- Apply quality improvement to clinical settings, where otolaryngology care is provided.
- Foster environment of openness and transparency in otolaryngology care.